Travere Therapeutics Kicks Off “Play It Forward” Campaign for FSGS Awareness

Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best biotech stocks to invest in now. On June 10, Travere Therapeutics launched a new awareness campaign called ‘Play It Forward’ to support the focal segmental glomerulosclerosis/FSGS community. FSGS is a rare kidney disease that affects both children and adults and is a leading cause of kidney failure.

FSGS is a rare proteinuric kidney disorder that is estimated to affect 40,000+ patients in the US, with similar numbers in Europe. It is characterized by the progressive scarring of the kidneys, often leading to kidney failure. The campaign debuted on the first-ever FSGS Awareness Day and features an anthem created by Grammy-winning musician Brian Kennedy and singer-songwriter David Rush, both of whom live with FSGS. The song celebrates the strength and unity of the FSGS community.

Travere Therapeutics Kicks Off "Play It Forward" Campaign for FSGS Awareness

A laboratory technician working on a solution of rare diseases, housed in a cholic acid capsule.

Kennedy and Rush encourage the FSGS community to use this soundtrack to share their creative expressions on social media. The campaign also includes a hero video where Kennedy and Rush discuss their FSGS journeys and the creation of their anthem. Through their shared experiences, they aim to foster connection and empower others living with FSGS. To engage with the campaign, individuals can search using the hashtag #PlayitForwardFSGS or visit RKDandMe.com/PlayItForwardFSGS.

Travere Therapeutics Inc. (NASDAQ:TVTX) is a biopharmaceutical company that identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the US.

While we acknowledge the potential of TVTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.